Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital fascia iliaca block with liposomal bupivacaine versus ropivacaine in elderly patients with intertrochanteric hip fracture
ChiCTR2400082747Phase 4Recruiting
- Sponsor
- Sichuan Provincial Orthopedic Hospital
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in intertrochanteric fracture comparing Liposomal bupivacaine group with Ropivacaine group (2 arms). Primary endpoint: Motor VAS score at 24 hours after fascia iliaca block. Started Apr 2024; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on ChiCTR2400082747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082747.